Daegu, South Korea

Hee Kyoung Jin


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hee Kyoung Jin: Innovator in Neurodegenerative Disease Research

Introduction

Hee Kyoung Jin is a prominent inventor based in Daegu, South Korea. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patented inventions. Her work focuses on developing solutions that can effectively target and treat these complex conditions.

Latest Patents

Hee Kyoung Jin holds a patent for a peptide that passes through the blood-brain barrier and specifically targets apoptotic cells in neurodegenerative brain disease-affected sites. This invention is crucial as it allows for the detection and imaging of apoptotic cells, as well as targeted drug delivery and theranosis for neurodegenerative diseases. The patent highlights the potential of this peptide in advancing treatment options for patients suffering from these debilitating conditions.

Career Highlights

Hee Kyoung Jin is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. Her role at this institution allows her to engage in cutting-edge research and collaborate with other experts in the field. Her dedication to innovation and research has positioned her as a key figure in the study of neurodegenerative diseases.

Collaborations

Hee Kyoung Jin has worked alongside notable colleagues, including Byung-Heon Lee and In-San Kim. These collaborations have further enhanced her research efforts and contributed to the advancement of knowledge in the field of neurodegenerative diseases.

Conclusion

Hee Kyoung Jin's innovative work in developing a peptide for neurodegenerative diseases showcases her commitment to improving patient outcomes. Her contributions to research and her patented invention are significant steps forward in the fight against these challenging conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…